av/aft-pharmaceutical-npv--big.svg

COM:AFTPHARM

AFT Pharmaceuticals

  • Stock

Last Close

2.68

08/11 04:00

Market Cap

309.35M

Beta: -

Volume Today

25.28K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
48.94M
-
56.24M
14.92%
57.67M
2.54%
69.05M
19.73%
79.88M
15.69%
84.87M
6.25%
105.24M
24.00%
112.86M
7.24%
129.83M
15.04%
155.82M
20.01%
195.41M
25.41%
cost of revenue
28.61M
-
35.08M
22.63%
36.43M
3.83%
43.21M
18.61%
45.88M
6.19%
44.40M
3.23%
57.33M
29.13%
64.36M
12.27%
68.54M
6.49%
83.66M
22.06%
107.14M
28.07%
gross profit
20.33M
-
21.16M
4.07%
21.24M
0.40%
25.84M
21.64%
34.00M
31.59%
40.48M
19.04%
47.91M
18.37%
48.50M
1.23%
61.30M
26.39%
72.16M
17.73%
88.27M
22.32%
selling and marketing expenses
6.58M
-
18.30M
178.24%
17.69M
3.33%
25.96M
46.79%
28.53M
9.89%
26.54M
6.98%
26.20M
1.27%
27.44M
4.71%
28.33M
3.25%
36.54M
28.99%
general and administrative expenses
1.35M
-
5.47M
306.16%
6.13M
11.96%
5.85M
4.55%
8.31M
41.99%
7.20M
13.31%
9.11M
26.51%
7.78M
14.56%
7.77M
0.13%
11.12M
43.08%
selling general and administrative expenses
15.77M
-
23.77M
50.70%
23.82M
0.19%
31.82M
33.58%
36.84M
15.80%
33.74M
8.41%
35.31M
4.66%
35.22M
0.26%
36.10M
2.50%
47.67M
32.02%
56.47M
18.47%
research and development expenses
3.91M
-
5.76M
47.38%
7.29M
26.54%
11.23M
54.00%
8.23M
26.69%
2.59M
68.55%
1.98M
23.34%
3.44M
73.24%
5.51M
60.23%
5.65M
2.56%
8.09M
43.31%
other expenses
2.07M
-
2.82M
36.25%
2.42M
13.95%
2.49M
2.81%
10.68M
328.37%
1.49M
86.08%
1.43M
3.63%
-189K
113.20%
cost and expenses
49.17M
-
67.49M
37.25%
69.90M
3.57%
86.58M
23.86%
91.29M
5.45%
81.05M
11.22%
95.41M
17.72%
104.13M
9.14%
110.15M
5.78%
138.70M
25.92%
171.70M
23.80%
operating expenses
20.56M
-
32.41M
57.59%
33.47M
3.29%
43.37M
29.57%
45.41M
4.71%
36.65M
19.29%
38.08M
3.90%
39.76M
4.42%
41.61M
4.65%
55.04M
32.27%
64.56M
17.31%
interest expense
1.82M
-
3.88M
113.20%
2.65M
31.61%
8.42M
217.38%
8.05M
4.34%
3.44M
57.27%
2.44M
29.24%
2.87M
17.99%
3.69M
28.30%
ebitda
3.41M
-
-5.76M
268.85%
-10.17M
76.49%
-14.13M
38.88%
-9.67M
31.52%
6.48M
166.95%
21.71M
235.19%
12.43M
42.74%
21.12M
69.88%
20.40M
3.43%
25.72M
26.10%
operating income
3.21M
-
-5.96M
285.83%
-10.44M
75.01%
-14.45M
38.44%
-10.01M
30.71%
6.16M
161.49%
20.93M
239.87%
11.33M
45.87%
20.08M
77.22%
18.67M
6.99%
23.71M
26.97%
depreciation and amortization
203K
-
202K
0.49%
268K
32.67%
326K
21.64%
340K
4.29%
319K
6.18%
781K
144.83%
1.10M
41.36%
1.04M
5.43%
1.72M
65.13%
2.01M
16.76%
total other income expenses net
-4.38M
-
-7.19M
64.08%
1.80M
124.97%
2.40M
33.83%
930K
61.30%
1.97M
111.94%
10.60M
437.54%
1.49M
85.97%
1.43M
3.63%
-189K
113.20%
-1.69M
793.12%
income before tax
-1.17M
-
-13.15M
1,022.44%
-11.99M
8.86%
-18.33M
52.88%
-12.67M
30.90%
-2.26M
82.16%
12.88M
670.03%
7.89M
38.75%
18.68M
136.91%
15.80M
15.45%
22.02M
39.37%
income tax expense
59K
-
282K
377.97%
-37.84K
113.42%
58K
253.29%
58K
0%
168K
189.66%
185K
10.12%
105K
43.24%
-1.16M
1,207.62%
5.14M
542.39%
6.41M
24.59%
net income
-1.11M
-
-12.87M
1,056.60%
-11.95M
7.15%
-18.39M
53.85%
-12.72M
30.80%
-2.43M
80.93%
12.69M
622.95%
7.78M
38.69%
19.85M
155.05%
10.65M
46.32%
15.61M
46.51%
weighted average shs out
74.40M
-
73.14M
1.70%
27.57M
62.30%
96.84M
251.20%
97.25M
0.42%
97.31M
0.06%
97.31M
0.00%
103.30M
6.15%
104.68M
1.34%
104.85M
0.16%
104.87M
0.02%
weighted average shs out dil
74.40M
-
73.14M
1.70%
27.58M
62.29%
97.11M
252.16%
97.25M
0.14%
97.31M
0.06%
97.31M
0.00%
103.30M
6.15%
104.68M
1.34%
104.85M
0.16%
104.87M
0.02%
eps
-0.01
-
-0.18
1,100.00%
-0.43
138.89%
-0.19
55.81%
-0.13
31.58%
-0.02
80.85%
0.12
581.93%
0.07
38.75%
0.19
158.50%
0.10
47.37%
0.15
50.00%
epsdiluted
-0.01
-
-0.18
1,100.00%
-0.43
138.89%
-0.19
55.81%
-0.13
31.58%
-0.02
80.85%
0.12
581.93%
0.07
41.08%
0.19
168.74%
0.10
47.37%
0.15
50.00%

All numbers in (except ratios and percentages)